Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Sep;49(9):1165-1176.
doi: 10.1016/j.ajic.2021.03.008. Epub 2021 Mar 24.

Are saliva and deep throat sputum as reliable as common respiratory specimens for SARS-CoV-2 detection? A systematic review and meta-analysis

Affiliations
Meta-Analysis

Are saliva and deep throat sputum as reliable as common respiratory specimens for SARS-CoV-2 detection? A systematic review and meta-analysis

Kazem Khiabani et al. Am J Infect Control. 2021 Sep.

Abstract

Objective: The COVID-19 pandemic raises an urgent need for large-scale control through easier, cheaper, and safer diagnostic specimens, including saliva and sputum. We aimed to conduct a systemic review and meta-analysis on the reliability and sensitivity of SARS-CoV-2 detection in saliva and deep throat sputum (DTS) compared to nasopharyngeal, combined naso/oropharyngeal, and oropharyngeal swabs.

Methods: This systematic review and meta-analysis was performed according to the PRISMA statement. The inclusion criteria were studies that specifically assessed a sample of saliva or DTS with at least one other respiratory specimen in patients with COVID-19 infection, based on RT-PCR tests. The DerSimonian-Laird bivariate random-effects model analysis performed using STATA software with the "metaprop" package.

Results: From 1598 studies, we retrieved 33 records, of which 26 studies were included for quantitative analysis. We found an overall sensitivity of 97% (95% confidence interval [CI], 86-100) for bronchoalveolar lavage fluid, 92% (95% CI, 80-99) for double naso/oropharyngeal swabs, 87% (95% CI, 77-95) for nasopharyngeal swabs, 83% (95% CI, 77-89) for saliva, 82% (95% CI, 76-88) for DTS, and 44% (95% CI, 35-52) for oropharyngeal swabs among symptomatic patients, respectively. Regardless of the type of specimens, the viral load and sensitivity in the severe patients were higher than mild and in the symptomatic patients higher than asymptomatic cases.

Conclusions: The present review provides evidence for the diagnostic value of different respiratory specimens and supports saliva and DTS as promising diagnostic tools for first-line screening of SARS-CoV-2 infection. However, the methods of sampling, storing, and laboratory assay need to be optimized and validated before introducing as a definitive diagnosis tool. Saliva, DTS, and nasopharyngeal swab showed approximately similar results, and sensitivity was directly related to the disease severity. This review revealed a relationship between viral load, disease severity, and test sensitivity. None of the specimens showed appropriate diagnostic sensitivity for asymptomatic patients.

Keywords: COVID-19; Nasopharyngeal swab; Oropharyngeal swab; RT-PCR diagnostic test; Sensitivity; Sputum.

PubMed Disclaimer

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig 1
The forest plot of SARS-CoV-2 detection sensitivity of saliva, based on RT-PCR analysis from symptomatic COVID-19 patients regarding the disease's severity.
Fig 2
Fig 2
The forest plot of SARS-CoV-2 detection sensitivity of deep throat sputum based on RT-PCR analysis from symptomatic COVID-19 patients regarding the disease's severity.
Fig 3
Fig 3
The forest plot of SARS-CoV-2 detection sensitivity of the nasopharyngeal sample and double naso/oropharyngeal samples based on RT-PCR analysis from symptomatic COVID-19 patients regarding the disease's severity.
Fig 4
Fig 4
(A) Summary of the quality assessment of the included saliva-based studies; (B) Summary of the quality assessment of the included DTS-based studies.

References

    1. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard 2020. Available at: https://covid19.who.int/. Accessed March 12, 2020.
    1. Centers for Disease Control and Prevention (CDC). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 2020. Available at:https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specim.... Accessed March 12, 2020.
    1. Sullivan PS, Sailey C, Guest JL, et al. Detection of SARS-CoV-2 RNA and antibodies in diverse samples: protocol to validate the sufficiency of provider-observed, home-collected blood, saliva, and oropharyngeal samples. JMIR Public Health Surv. 2020;6:e19054. - PMC - PubMed
    1. Santosh TS, Parmar R, Anand H, Srikanth K, Saritha M. A review of salivary diagnostics and its potential implication in detection of Covid-19. Cureus. 2020;12:e7708. - PMC - PubMed
    1. Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection—challenges and implications. N Engl J Med. 2020;383:e38. - PubMed